Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19

Detalhes bibliográficos
Autor(a) principal: Dieter, Cristine
Data de Publicação: 2023
Outros Autores: Brondani, Letícia de Almeida, Lemos, Natália Emerim, Schaeffer, Ariell Freires, Boeckel, Caroline Zanotto de, Ramos, Denise Taurino, Girardi, Eliandra, Pellenz, Felipe Mateus, Camargo, Joiza Lins, Moresco, Karla Suzana, Silva, Lucas Lima da, Aubin, Mariana Rauback, Oliveira, Mayara Souza de, Rech, Tatiana Helena, Canani, Luis Henrique Santos, Gerchman, Fernando, Leitão, Cristiane Bauermann, Crispim, Daisy
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/265579
Resumo: Although advanced age, male sex, and some comorbidities impact the clinical course of COVID-19, these factors only partially explain the inter-individual variability in disease severity. Some studies have shown that genetic polymorphisms contribute to COVID-19 severity; however, the results are inconclusive. Thus, we investigated the association between polymorphisms in ACE1, ACE2, DPP9, IFIH1, IFNAR2, IFNL4, TLR3, TMPRSS2, and TYK2 and the clinical course of COVID-19. A total of 694 patients with COVID-19 were categorized as: (1) ward inpatients (moderate symptoms) or patients admitted at the intensive care unit (ICU; severe symptoms); and (2) survivors or non-survivors. In females, the rs1990760/IFIH1 T/T genotype was associated with risk of ICU admission and death. Moreover, the rs1799752/ACE1 Ins and rs12329760/TMPRSS2 T alleles were associated with risk of ICU admission. In non-white patients, the rs2236757/IFNAR2 A/A genotype was associated with risk of ICU admission, while the rs1799752/ACE1 Ins/Ins genotype, rs2236757/IFNAR2 A/A genotype, and rs12329760/TMPRSS2 T allele were associated with risk of death. Moreover, some of the analyzed polymorphisms interact in the risk of worse COVID19 outcomes. In conclusion, this study shows an association of rs1799752/ACE1, rs1990760/IFIH1, rs2236757/IFNAR2, rs12329760/TMPRSS2, and rs2304256/TYK2 polymorphisms with worse COVID19 outcomes, especially among female and non-white patients.
id UFRGS-2_7f6926a7a2a385a7694c3a7bc2fe8940
oai_identifier_str oai:www.lume.ufrgs.br:10183/265579
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Dieter, CristineBrondani, Letícia de AlmeidaLemos, Natália EmerimSchaeffer, Ariell FreiresBoeckel, Caroline Zanotto deRamos, Denise TaurinoGirardi, EliandraPellenz, Felipe MateusCamargo, Joiza LinsMoresco, Karla SuzanaSilva, Lucas Lima daAubin, Mariana RaubackOliveira, Mayara Souza deRech, Tatiana HelenaCanani, Luis Henrique SantosGerchman, FernandoLeitão, Cristiane BauermannCrispim, Daisy2023-10-03T03:35:36Z20232073-4425http://hdl.handle.net/10183/265579001173168Although advanced age, male sex, and some comorbidities impact the clinical course of COVID-19, these factors only partially explain the inter-individual variability in disease severity. Some studies have shown that genetic polymorphisms contribute to COVID-19 severity; however, the results are inconclusive. Thus, we investigated the association between polymorphisms in ACE1, ACE2, DPP9, IFIH1, IFNAR2, IFNL4, TLR3, TMPRSS2, and TYK2 and the clinical course of COVID-19. A total of 694 patients with COVID-19 were categorized as: (1) ward inpatients (moderate symptoms) or patients admitted at the intensive care unit (ICU; severe symptoms); and (2) survivors or non-survivors. In females, the rs1990760/IFIH1 T/T genotype was associated with risk of ICU admission and death. Moreover, the rs1799752/ACE1 Ins and rs12329760/TMPRSS2 T alleles were associated with risk of ICU admission. In non-white patients, the rs2236757/IFNAR2 A/A genotype was associated with risk of ICU admission, while the rs1799752/ACE1 Ins/Ins genotype, rs2236757/IFNAR2 A/A genotype, and rs12329760/TMPRSS2 T allele were associated with risk of death. Moreover, some of the analyzed polymorphisms interact in the risk of worse COVID19 outcomes. In conclusion, this study shows an association of rs1799752/ACE1, rs1990760/IFIH1, rs2236757/IFNAR2, rs12329760/TMPRSS2, and rs2304256/TYK2 polymorphisms with worse COVID19 outcomes, especially among female and non-white patients.application/pdfengGenes. Basel. Vol. 14, no. 1 (2023), artigo 19, 21 p.SARS-CoV-2COVID-19Polimorfismo genéticoFatores de riscoPrognósticoGenesMortalidadeUnidades de terapia intensivaCuidados críticosGenótipoMortalidadePolymorphismsACE1IFIH1IFNAR2TMPRSS2TYK2Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19Estrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001173168.pdf.txt001173168.pdf.txtExtracted Texttext/plain75826http://www.lume.ufrgs.br/bitstream/10183/265579/2/001173168.pdf.txtc14a39176e02143f1ceb590be1718d00MD52ORIGINAL001173168.pdfTexto completo (inglês)application/pdf372397http://www.lume.ufrgs.br/bitstream/10183/265579/1/001173168.pdfab5229bb1595a07182ded8c2ca333db7MD5110183/2655792023-12-21 04:31:11.569541oai:www.lume.ufrgs.br:10183/265579Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2023-12-21T06:31:11Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
title Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
spellingShingle Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
Dieter, Cristine
SARS-CoV-2
COVID-19
Polimorfismo genético
Fatores de risco
Prognóstico
Genes
Mortalidade
Unidades de terapia intensiva
Cuidados críticos
Genótipo
Mortalidade
Polymorphisms
ACE1
IFIH1
IFNAR2
TMPRSS2
TYK2
title_short Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
title_full Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
title_fullStr Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
title_full_unstemmed Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
title_sort Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19
author Dieter, Cristine
author_facet Dieter, Cristine
Brondani, Letícia de Almeida
Lemos, Natália Emerim
Schaeffer, Ariell Freires
Boeckel, Caroline Zanotto de
Ramos, Denise Taurino
Girardi, Eliandra
Pellenz, Felipe Mateus
Camargo, Joiza Lins
Moresco, Karla Suzana
Silva, Lucas Lima da
Aubin, Mariana Rauback
Oliveira, Mayara Souza de
Rech, Tatiana Helena
Canani, Luis Henrique Santos
Gerchman, Fernando
Leitão, Cristiane Bauermann
Crispim, Daisy
author_role author
author2 Brondani, Letícia de Almeida
Lemos, Natália Emerim
Schaeffer, Ariell Freires
Boeckel, Caroline Zanotto de
Ramos, Denise Taurino
Girardi, Eliandra
Pellenz, Felipe Mateus
Camargo, Joiza Lins
Moresco, Karla Suzana
Silva, Lucas Lima da
Aubin, Mariana Rauback
Oliveira, Mayara Souza de
Rech, Tatiana Helena
Canani, Luis Henrique Santos
Gerchman, Fernando
Leitão, Cristiane Bauermann
Crispim, Daisy
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Dieter, Cristine
Brondani, Letícia de Almeida
Lemos, Natália Emerim
Schaeffer, Ariell Freires
Boeckel, Caroline Zanotto de
Ramos, Denise Taurino
Girardi, Eliandra
Pellenz, Felipe Mateus
Camargo, Joiza Lins
Moresco, Karla Suzana
Silva, Lucas Lima da
Aubin, Mariana Rauback
Oliveira, Mayara Souza de
Rech, Tatiana Helena
Canani, Luis Henrique Santos
Gerchman, Fernando
Leitão, Cristiane Bauermann
Crispim, Daisy
dc.subject.por.fl_str_mv SARS-CoV-2
COVID-19
Polimorfismo genético
Fatores de risco
Prognóstico
Genes
Mortalidade
Unidades de terapia intensiva
Cuidados críticos
Genótipo
Mortalidade
topic SARS-CoV-2
COVID-19
Polimorfismo genético
Fatores de risco
Prognóstico
Genes
Mortalidade
Unidades de terapia intensiva
Cuidados críticos
Genótipo
Mortalidade
Polymorphisms
ACE1
IFIH1
IFNAR2
TMPRSS2
TYK2
dc.subject.eng.fl_str_mv Polymorphisms
ACE1
IFIH1
IFNAR2
TMPRSS2
TYK2
description Although advanced age, male sex, and some comorbidities impact the clinical course of COVID-19, these factors only partially explain the inter-individual variability in disease severity. Some studies have shown that genetic polymorphisms contribute to COVID-19 severity; however, the results are inconclusive. Thus, we investigated the association between polymorphisms in ACE1, ACE2, DPP9, IFIH1, IFNAR2, IFNL4, TLR3, TMPRSS2, and TYK2 and the clinical course of COVID-19. A total of 694 patients with COVID-19 were categorized as: (1) ward inpatients (moderate symptoms) or patients admitted at the intensive care unit (ICU; severe symptoms); and (2) survivors or non-survivors. In females, the rs1990760/IFIH1 T/T genotype was associated with risk of ICU admission and death. Moreover, the rs1799752/ACE1 Ins and rs12329760/TMPRSS2 T alleles were associated with risk of ICU admission. In non-white patients, the rs2236757/IFNAR2 A/A genotype was associated with risk of ICU admission, while the rs1799752/ACE1 Ins/Ins genotype, rs2236757/IFNAR2 A/A genotype, and rs12329760/TMPRSS2 T allele were associated with risk of death. Moreover, some of the analyzed polymorphisms interact in the risk of worse COVID19 outcomes. In conclusion, this study shows an association of rs1799752/ACE1, rs1990760/IFIH1, rs2236757/IFNAR2, rs12329760/TMPRSS2, and rs2304256/TYK2 polymorphisms with worse COVID19 outcomes, especially among female and non-white patients.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-10-03T03:35:36Z
dc.date.issued.fl_str_mv 2023
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/265579
dc.identifier.issn.pt_BR.fl_str_mv 2073-4425
dc.identifier.nrb.pt_BR.fl_str_mv 001173168
identifier_str_mv 2073-4425
001173168
url http://hdl.handle.net/10183/265579
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Genes. Basel. Vol. 14, no. 1 (2023), artigo 19, 21 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/265579/2/001173168.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/265579/1/001173168.pdf
bitstream.checksum.fl_str_mv c14a39176e02143f1ceb590be1718d00
ab5229bb1595a07182ded8c2ca333db7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv lume@ufrgs.br
_version_ 1817725174712107008